Dr Nandakumar Jairam is CEO & Jasdeep Singh new COO of Columbia Asia Hospital

IMT News Desk
IMT News Desk
· 3 min read

Columbia Asia Hospitals, India, has announced the appointment of Dr. Nandakumar Jairam as their new CEO and Mr. Jasdeep Singh as the new COO. Both Dr. Jairam and Mr. Singh have assumed responsibilities in their new roles from April 2017. The Columbia Asia Group is owned by more than 150 private equity companies, fund management organizations and individual investors. The group currently operates eleven facilities in India and has presence in Ahmedabad, Bangalore, Gurgaon, Ghaziabad, Kolkata, Mysore, Patiala and Pune. The company also operates hospitals in Malaysia (11), Vietnam (3), and Indonesia (3). The Indian management operations are managed from its office in Bangalore.

Dr. Jairam has been associated with Columbia Asia Hospitals for more than twelve years and has served the organization as the Chairman and Group Medical Director.

“I have been with Columbia Asia Hospitals since its inception in India. Joining Columbia Asia helped me realize my dream and ambition to set up high quality health care facilities in India to provide world class health care to our citizens and patients from overseas. I am extremely thankful to the Board and pleased to have accepted this role.  With a strong team and my previous experience, I will strive to take the Group ahead to meet the expectation of the shareholders,” said Dr. Jairam.

Dr. Jairam is also the Chairman of the NABH under the auspices of QCI (Quality Council of India), and was Chairman of the health services committee of FICCI. He is the founder member of NATHEALTH and GAPIO as well as the founder trustee for Terry Fox foundation Bangalore until its existence. He founded Krishna charitable trust.

An alumnus of Bangalore Medical College, National College, Basavanagudi and Bishop Cottons School, Bangalore, India, Dr. Jairam has practiced as a surgeon and held academic positions including being a Professor of Surgery and HOD at St John’s medical college and hospital. He has 40+ years in the profession.

The hospital group has also appointed Mr. Jasdeep Singh, as the new COO on board. Mr. Singh comes with 17 years of rich experience in operations & P&L management and has worked with brands including Fortis Healthcare Ltd. He joined Columbia Asia Hospitals, from his position as the CEO at Milann-The Fertility Centre.

“I am delighted to be a part of this fantastic organization which enjoys the reputation of being a large (global), ethical and technology driven healthcare provider. Over the years Columbia Asia has created a warm spot for itself and is regarded for the international quality of clinical and support services it offers to all its patients. I am sure we will be able to create a stronger presence in the Indian market in the times to come,” said Singh.

Mr. Singh has deep-rooted knowledge and understanding of the healthcare sector and has served the industry for over 17 years now. Graduating in Hotel Management from the Welcomgroup Graduate School of Hotel Administration, Mr. Singh pursued MBA from Ohio Manipal School of Business. This apart, among his other accomplishments, he has done a certificate course in Hospital Management from IIM Ahmedabad and a Hospital Management Program from Singapore Management University, Singapore.

In the last 17 years of his professional journey he has worked in large healthcare players such as Manipal Hospitals and Fortis Healthcare Ltd. At Fortis, he grew the ranks by working in different functions as well as in multiple hospitals. He has been instrumental in creating process efficiency in hospital operations and led various multi-specialty hospitals including the flagship hospital – Fortis Memorial Research Institute at Gurgaon.

 

Read Next

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk
National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare
News
May 18, 2026

National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare

The National AI Doctors Mission (NAIDM) has been formally launched in New Delhi, marking a major step toward integrating artificial intelligence into everyday clinical practice across India’s public and private healthcare system. The initiative, led by Medical Dialogues in collaboration with the National Medical Forum, aims to make AI “useful and usable” for frontline doctors rather than […]
Article by: IMT News Desk
Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore
News
May 18, 2026

Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore

Gland Pharma shares extended gains in the capital markets after the company posted a standout Q4 performance, with consolidated net profit jumping 97% year‑on‑year to ₹367 crore, riding on a sharp improvement in operating leverage and a strong base‑business showing in the US. Revenue for the quarter rose 22% YoY to ₹1,743 crore, while EBITDA surged 48% YoY […]
Article by: IMT News Desk